Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nemecek

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Nature Medicine|October 3, 2018
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaElena J Orlando, Xia Han, Catherine Tribouley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2018
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant ConsortiumEneida R Nemecek, Ralf A Hilger, Alexia Adams, et al.
Transplantation and Cellular Therapy|April 9, 2023
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell TherapyNicolas Gazeau, Emily C Liang, Qian Vicky Wu, et al.
Transplantation and Cellular Therapy|August 30, 2021
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th YearHelen E Heslop, Edward A Stadtmauer, John E Levine, et al.
Blood Advances|October 11, 2022
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 studyGeoffrey D E Cuvelier, Bernard Ng, Sayeh Abdossamadi, et al.
Blood|September 17, 2021
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host diseaseDivya Subburaj, Bernard Ng, Amina Kariminia, et al.
Blood|January 31, 2016
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failurePaul G Richardson, Marcie L Riches, Nancy A Kernan, et al.
Blood|May 3, 2019
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoffrey D E Cuvelier, Eneida R Nemecek, Justin T Wahlstrom, et al.
The New England Journal of Medicine|February 1, 2018
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaShannon L Maude, Theodore W Laetsch, Jochen Buechner, et al.
Blood|February 13, 2020
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R Schultz, Amina Kariminia, Bernard Ng, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Nature Medicine|October 3, 2018
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaElena J Orlando, Xia Han, Catherine Tribouley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2018
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant ConsortiumEneida R Nemecek, Ralf A Hilger, Alexia Adams, et al.
Transplantation and Cellular Therapy|April 9, 2023
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell TherapyNicolas Gazeau, Emily C Liang, Qian Vicky Wu, et al.
Transplantation and Cellular Therapy|August 30, 2021
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th YearHelen E Heslop, Edward A Stadtmauer, John E Levine, et al.
Blood Advances|October 11, 2022
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 studyGeoffrey D E Cuvelier, Bernard Ng, Sayeh Abdossamadi, et al.
Blood|September 17, 2021
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host diseaseDivya Subburaj, Bernard Ng, Amina Kariminia, et al.
Blood|January 31, 2016
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failurePaul G Richardson, Marcie L Riches, Nancy A Kernan, et al.
Blood|May 3, 2019
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoffrey D E Cuvelier, Eneida R Nemecek, Justin T Wahlstrom, et al.
The New England Journal of Medicine|February 1, 2018
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaShannon L Maude, Theodore W Laetsch, Jochen Buechner, et al.
Blood|February 13, 2020
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R Schultz, Amina Kariminia, Bernard Ng, et al.
Pageof 7